[Immunoblastic lymphadenopathy-like T cell lymphoma with high level of serum interleukin-2 and various allergic reactions].
Tsujisaki
Masayuki
M
Nakahara
Seiya
S
Kazama
Yoshie
Y
Shimizu
Haruo
H
Yoshimoto
Mitsuru
M
Takahashi
Tohru
T
Okada
Yoshimasa
Y
Sasaki
Shigeru
S
Imai
Kohzoh
K
D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy / Q000209:etiology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage; D017449:Dermatitis, Allergic Contact / Q000188:drug therapy / Q000209:etiology; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D006942:Hypergammaglobulinemia / Q000188:drug therapy / Q000209:etiology; D007119:Immunoblastic Lymphadenopathy / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D007073:Immunoglobulin E; D007376:Interleukin-2 / Q000097:blood*; D016399:Lymphoma, T-Cell / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
D007376:Interleukin-2; D007073:Immunoglobulin E; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone